\
&
Contact us
\
&
Contact us
Published on | 3 months ago
Programmes HealthThe Commission has recently adopted the EU4Health Work Programme for 2025. The Work Programme supports the EU’s priorities in health policy, to protect citizens and boost innovation in Europe. Among the areas of focus are cardiovascular health, digital health, cancer, health technology assessment, crisis preparedness, medicines and medical devices and substances of human origin. The EU4Health programme provides funding through grants and public procurement to contribute to a healthier Europe.
The Commission will draw on synergies with other EU funding programmes, such as Horizon Europe, Digital Europe Programme or European Social Fund Plus, to optimise the EU’s health investments.
Consult the 2025 EU4Health Work Programme here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Research Infrastructures Horizon Europe Digital Europe
Building on the revised Charter for access to research infrastructures , this new Charter will be specifically aimed at facilitating access of companies. It will make it easier for companies, especially small and medium-sized businesses (SMEs), startups and scaleups, to access Europe’s world-class research and technology... read more
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
